US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.01

-0.3856-0.93%

Volume:21.31K

Turnover:875.77K

Market Cap:1.06B

PE:- -

High:41.29

Open:41.29

Low:41.01

Close:41.40

52wk High:42.87

52wk Low:27.30

Shares:25.75M

Float Shares:25.75M

Volume Ratio:1.99

T/O Rate:0.08%

Dividend:0.42

Dividend Rate:1.03%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Champions Oncology Q1 Revenue Rises on Research Services Business

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

AbbVie Declares Quarterly Cash Dividend of $1.73 a Share

Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share

THOMSON REUTERS

BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod

Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors

Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors

AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors

Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says

MT Newswires Live

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026

Bristol-Myers Squibb is Maintained at Hold by HSBC

Eli Lilly is Maintained at Reduce by HSBC

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS

Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/FTXH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":41.0101,"timestamp":1789749611098,"preClose":41.3957,"halted":0,"volume":21306,"delay":0,"changeRate":-0.00931497715946334,"floatShares":25750002,"shares":25750002,"eps":0,"marketStatus":"Trading","change":-0.3856,"latestTime":"09-18 12:42:14 EDT","open":41.291,"high":41.291,"low":41.0101,"amount":875772.90312,"amplitude":0.006786,"askPrice":41.04,"askSize":1002,"bidPrice":41,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":41.3957,"sharesOutstanding":850002,"nav":40.79,"aum":1050342581.58,"dividendRate":0.010295,"bidAskSpread":0.001511,"postHourTrading":{"tag":"盘后","latestPrice":41.39,"preClose":41.3957,"latestTime":"19:48 EDT","volume":107,"amount":4440.4357,"timestamp":1789688883270,"change":-0.0057,"changeRate":-0.000138,"amplitude":0},"volumeRatio":1.990659,"impliedVol":0.216,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25750002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.990659,"shares":25750002,"dividePrice":0.4222,"high":41.291,"amplitude":0.006786,"preClose":41.3957,"low":41.0101,"week52Low":27.3,"pbRate":"--","week52High":42.87,"institutionHeld":0,"latestPrice":41.0101,"committee":-0.998006,"eps":0,"divideRate":0.010295,"volume":21306,"delay":0,"ttmEps":0,"open":41.291,"prevYearClose":32.9401,"prevWeekClose":40.4666,"prevMonthClose":41.3525,"prevQuarterClose":38.1897,"fiveDayClose":40.4666,"twentyDayClose":41.66,"sixtyDayClose":36.777},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FTXH","amount":0.0892,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666515425","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515425?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:31","pubTimestamp":1789072260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  rallied 1.63% to $255.00 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,591.70 and Dow Jones Industrial Average  falling 0.60% to 52,064.10.This was the stock's second consecutive day of gains.AbbVie Inc. closed 4.66% below its 52-week high of $267.47, which the company reached on July 29th.The stock outperformed some of its competitors Thursday, as Johnson & Johnson  fell 0.27% to $266.35, Pfizer Inc.  fell 0.47% to $27.65, and Amgen Inc.  fell 2.25% to $382.47.Trading volume  remained 922,509 below its 50-day average volume of 5.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1496350171.SGD","LU0689626769.HKD","LU1718418525.SGD","BK4581","LU0395794307.EUR","LU0985320562.USD","LU0211328371.USD","LU1267930573.SGD","LU2347655073.USD","LU2237443622.USD","LU1023059063.AUD","FTXH","XLV","LU2468319806.SGD","PPH","IE00B19Z3581.USD","IE0002270589.USD","LU2237443978.SGD","LU0203345920.USD","TRUH","LU2129689431.USD","LU1934455194.USD","LU1989772840.SGD","LU1037948897.HKD","LU1551013342.USD","LU1923622614.USD","RXL","LU1244550494.USD","BK4559","IE0004445239.USD","LU1244550577.SGD","LU0472753341.HKD","SG9999011175.SGD","LU2237443895.HKD","IE00B3PB1722.GBP","LU1551013425.SGD","LU0820561909.HKD","IE00BVYPNW00.USD","SG9999015945.SGD","LU0234572021.USD","LU0203347892.USD","LU1585245621.USD","LU0057025933.USD","IYH","LU0456855351.SGD","LU1236620834.HKD","SG9999015978.USD","LU0098860793.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU2237443549.SGD","BK4585","LU2112291526.USD","LU2237443382.USD","FHLC","LU1057294990.SGD","LU0310799852.SGD","LU0965509101.SGD","LU1074936037.SGD","LU1496350502.SGD","BK4566","BK4139","IE000BZT7R73.USD","IE00B19Z3B42.SGD","LU0965509283.SGD","LU0198837287.USD","LU0820561818.USD","IE00BJJMRZ35.SGD","LU0882574055.USD","IE0009355771.USD","IE00BSNM7G36.USD","LU0861579265.USD","LU1989772923.USD","LU0320765646.SGD","IE000MB6IJN5.SGD","LU2133065610.SGD","IE000SO60NU8.SGD","LU0289739343.SGD","LU1934455277.USD","LU0432979614.USD","LU0823416689.USD","LU1061106388.HKD","LU0912757837.SGD","LU1839511570.USD","LU0069063385.USD","LU2089984988.USD","LU0256863811.USD","LU0553294199.USD","LU0128525929.USD","LU1934455863.HKD","LU0859254822.USD","LU2125909593.SGD","LU0708994859.HKD","LU2087621335.USD","LU0943347566.SGD","LU0211327993.USD","VHT","LU0114720955.EUR","LU1003077747.HKD","LU0511384066.AUD","LU0795875086.SGD","LU1670628061.USD","LU0868494708.USD","IE00BGHQF631.EUR","LU2023251221.USD","LU1430594728.SGD","LU2357627491.SGD","LU0942090050.USD","LU2237443465.HKD","IE00B4R5TH58.HKD","LU0289961442.SGD","LU0726765562.USD","AGNG","LU0158827948.USD","IE00BLSP4452.SGD","BK4534","LU0417517546.SGD","LU0124676726.USD","LU1670627923.USD","LU1732799900.SGD","IE00BFTCPJ56.SGD","LU0170899867.USD","IE000WAW04H5.SGD","ABBV","IE00BN8TJ469.HKD","LU0289739699.SGD","LU1989771016.USD","IE0000B7K699.USD","LU2347655156.SGD","GLAM","SG9999003800.SGD","LU0256863902.USD","LU0058720904.USD","LU2089283258.USD","LU1244550221.USD","LU2089284900.SGD","LU1093756168.USD","LU1093756325.SGD","LU1267930490.SGD","SG9999015952.SGD","IE000F7OJYX1.SGD","LU0310800379.SGD","LU1732800096.USD","IXJ","LU0661504455.SGD","LU0965509010.AUD","MEDX","IE00BVYPNV92.GBP","JDOC","IE00BBT3K403.USD","LU0965508806.USD","LU0795875169.SGD","LU0234570918.USD","BK4588","LU1037948541.HKD","LU1162221912.USD","IE00BDGV0183.EUR","LU2433249047.HKD","LU2129689514.USD","LU2125909247.SGD","LU0029864427.USD","LU0868494617.USD","SG9999015986.USD","SG9999001440.SGD","PJP","LU1929549753.HKD","LU0949170772.SGD","BK4533","LU0689472784.USD","LU0738911758.USD","IE00BLSP4239.USD","LU0545039389.USD","LU1291159041.SGD","LU1983299246.USD","IE00B2B36J28.USD","BK4550","LU0122379950.USD","LU2129689605.HKD","LU1236620750.USD","IE00B42XCP33.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513067","title":"Champions Oncology Q1 Revenue Rises on Research Services Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513067","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513067?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071012,"startTime":"0","endTime":"0","summary":"Champions Oncology Q1 revenue rises on research services businessOverviewUS translational oncology research firm's fiscal Q1 revenue grew 8.8% yr/yrOncology services margin improved to 51% from 43% in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL1N45210N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0784384876.USD","LU3187612489.SGD","LU0211326839.USD","LU0171276677.USD","LU0211327993.USD","LU1323610961.USD","BMY","LU0211328371.USD","LU0868494617.USD","BBH","LU2357627491.SGD","PBE","03165","LU1868836757.USD","BIB","LU0640478417.SGD","LU1430594728.SGD","LU0321505439.SGD","LU0827474353.SGD","LU1084165304.USD","LU1814569148.SGD","LU0096364046.USD","PJP","LU1273509221.SGD","LU2293690082.USD","LU1267930573.SGD","IHE","LU2539964713.USD","LU0949170426.SGD","LU0823416689.USD","LU1078025761.USD","LU1119994496.HKD","FTXH","AZN.UK","LU2360032135.SGD","LU1074936037.SGD","LU1355424745.HKD","CSBR","LU1153584641.USD","AMGN","IBBQ","LU1883839398.USD","IBB","LU0203345920.USD","LU1261432733.SGD","LU1585245621.USD","LU1093756168.USD","TBXU","LU0267386448.USD","LU1196032939.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513650","title":"Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513650","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513650?lang=en_us&edition=fundamental","pubTime":"2026-09-11 03:50","pubTimestamp":1789069845,"startTime":"0","endTime":"0","summary":"Insight Guru flags valuation flip as Merck trades at 52.2x operating profit vs Lilly 25.3xInsight Guru analysis flagged a valuation reversal between Merck and Eli Lilly, with Merck now trading at a pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL3jvMXh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","LU2125154935.USD","LU1712237335.SGD","VHT","LU0466842654.USD","LU0203201768.USD","LU1093756168.USD","IE0005OL40V9.USD","LU2125909247.SGD","LU0265550946.USD","LU2237443465.HKD","FTXH","LU0109391861.USD","LU1057294990.SGD","LU2237443622.USD","IE00BKPKM429.USD","LU0683600562.USD","SG9999018865.SGD","LU2471134796.USD","LU0158827948.USD","LU2023251221.USD","LU0096364046.USD","LU1267930730.SGD","MEDX","LU0122379950.USD","LU2357627491.SGD","LU0823416689.USD","LU2756315664.SGD","LU2361044865.SGD","BK4599","LU0985320562.USD","LU0225283273.USD","LU0133085943.USD","LU0210536198.USD","SG9999015341.SGD","LU1548497426.USD","LLYZ","BK4559","LU0689472784.USD","LU2462591350.SGD","LU2552382132.HKD","SG9999014575.USD","LU1868837300.USD","BK4550","MEDI","IE00BK4W5M84.HKD","IE00BN29S564.USD","LU0787776722.HKD","LU1699723380.USD","LU2089284900.SGD","SGXZ51526630.SGD","SG9999002224.SGD","LU0208291251.USD","LU0198837287.USD","SG9999015978.USD","LU0353189763.USD","LU2896262040.SGD","GDOC","LU2461242641.AUD","LU1989771016.USD","IE00BKDWB100.SGD","LU2063271972.USD","SGXZ31699556.SGD","SG9999001440.SGD","LU0266013472.USD","LU0211331839.USD","LU0265550359.USD","LU1032466523.USD","LU0354030511.USD","IE00BWXC8680.SGD","LU1917777945.USD","IE00BK4W5L77.USD","LU0708995401.HKD","LU1629891620.HKD","LU2089984988.USD","LU1720051017.SGD","LU1127390331.HKD","LU1116320901.HKD","LU1989772840.SGD","LU2271345857.HKD","IE00BJT1NW94.SGD","LU0174119429.USD","LU2433249047.HKD","LU2468319806.SGD","LU1868836757.USD","BMED","LU0323591593.USD","LU0820561909.HKD","LU1868836591.USD","LU0471298777.SGD","LU0316494557.USD","LU0868494708.USD","LU1069344957.HKD","LU2746668974.SGD","LU1941712348.USD","LU2750360997.AUD","IE00B4JS1V06.HKD","IE00BLSP4452.SGD","LU0965509101.SGD","SG9999002232.USD","LU0861579265.USD","LU0106261372.USD","LU1232071149.USD","LU0980610538.SGD","LU1979441026.SGD","ELIS","LU0672654240.SGD","LU0061475181.USD","LU2750360641.GBP","LU2471134879.HKD","LU2237443978.SGD","LU2357305700.SGD","LU0234572021.USD","LU2265009873.SGD","LU2237443382.USD","LU0965508806.USD","LU2360032135.SGD","LU2456880835.USD","LU1023059063.AUD","PAWZ","LU2168564495.EUR","SGXZ81514606.USD","LU1585245621.USD","MRK","LU2168564222.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","IE00B2B36J28.USD","LU0345770308.USD","LU2746668461.USD","LU2087625088.SGD","LU0130517989.USD","LU2023250843.SGD","IE00BBT3K403.USD","SG9999014567.USD","LU1280957306.USD","ILDR","LU1974910355.USD","LU0456855351.SGD","CURE","SG9999001176.USD","LU2756315318.SGD","LU0353189680.USD","BK4516","MHIP","LLII","LU2491050071.SGD","LU0079474960.USD","LU2237443549.SGD","SGXZ57979304.SGD","LU1037948541.HKD","LU1066053197.SGD","LU1941712264.USD","LU1035773651.USD","LU1037948897.HKD","IE00B775H168.HKD","LU0345770993.USD","BK4533","IE000M9KFDE8.USD","LU2462157665.USD","IE00B1XK9C88.USD","IE00BN8TJ469.HKD","LU0320765992.SGD","SG9999014559.SGD","LU1988902786.USD","LU0820561818.USD","SG9999015986.USD","LU1929549753.HKD","LU2361044949.HKD","LU1923622614.USD","BK4588","LU2211815571.USD","LU0965509010.AUD","LU1623119135.USD","LU0097036916.USD","LU2108987350.USD","WDNA","IE00BJLML261.HKD","LU1035775433.USD","LU0124676726.USD","LU1983299246.USD","LU2125154778.USD","LU0070302665.USD","LU0786609619.USD","ELIL","IE00B1BXHZ80.USD","LU0964807845.USD","LU0823434740.USD","LU1868837136.USD","PPH","LU2471134523.USD","LU0471298694.HKD","BK4581","LU2552382058.USD","LU2237443895.HKD","LU0098860793.USD","IE00BSNM7G36.USD","LU0882574055.USD","LU0130102774.USD","HRTS","LU1064131342.USD","LU2417539215.USD","LU0640476718.USD","LU0889565916.HKD","LU0203202063.USD","LU1551013342.USD","LU0943347566.SGD","LU1061106388.HKD","LU2089283258.USD","LU0289739699.SGD","LU2168564065.EUR","LU2023250504.SGD","LU1989772923.USD","SG9999014542.SGD","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","LU1069347547.HKD","GB00BDT5M118.USD","IE00B7KXQ091.USD","LU2491049909.HKD","THNR","IHE","SG9999015358.SGD","BK4585","LLYX","XLV","LU0417517546.SGD","LU2112291526.USD","LU2168564149.EUR","FHLC","LU1366192091.USD","LU1116320737.USD","LU0942090050.USD","LU1720051108.HKD","LU0256863902.USD","IYH","LU0109394709.USD","LU2552382215.SGD","SGXZ99366536.SGD","LU0432979614.USD","IE0009355771.USD","LU0868494617.USD","LU1934455863.HKD","LU1934455194.USD","IE00BFSS7M15.SGD","LU0158827781.USD","SG9999014880.SGD","LU1691799644.USD","LU0648001328.SGD","LU0203347892.USD","LU2168563687.JPY","LU0058720904.USD","LU2361045086.USD","LU2106854487.HKD","LU1145028129.USD","TMED","LU1430594728.SGD","LU2237438978.USD","LU0882574139.USD","LU0820562030.AUD","LLY","PJP","LU0859254822.USD","LU1323610961.USD","SG9999001176.SGD","LU2111349929.HKD","IE0002141913.USD","IE00BJJMRY28.SGD","LU0238689110.USD","LU0006306889.USD","LU0965509283.SGD","LU1814569148.SGD","LU0354030438.USD","LU1162221912.USD","IE00BLSP4239.USD","LU0094547139.USD","SG9999014914.USD","LU0320765059.SGD","LU1066051225.USD","LU1291159041.SGD","SG9999018857.SGD","LU2125909593.SGD","LU2264538146.SGD","SG9999014898.SGD","SG9999015945.SGD","LU1804176565.USD","LU0689626769.HKD","LU2023250330.USD","LU0477156953.USD","LU0823434583.USD","IE0004445015.USD","SG9999017495.SGD","LU0385154629.USD","CANC","JDOC","SG9999014906.USD","LU2491050154.USD","LU2360106947.USD","IE0004445239.USD","RXL","LU1571399168.USD","LU1551013425.SGD","LU0114720955.EUR","SG9999015952.SGD","LU0203345920.USD","LU2028103732.USD","LU2602419157.SGD","LU0256863811.USD","LU1934455277.USD","LU1066051498.USD","IXJ","LU1201861249.SGD","IE0001KFT4U8.USD","TRUH","BK4007","BK4534","IE00B4R5TH58.HKD","IE00BJJMRX11.SGD","LU1868836914.USD","LU2236285917.USD","LU1093756325.SGD","LU2471134952.CNY","SG9999013999.USD","AGNG","LU2324357040.USD","LU1066051811.HKD","LU2213496289.HKD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518829","title":"Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518829","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666518829?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:40","pubTimestamp":1789065600,"startTime":"0","endTime":"0","summary":"Revolution Medicines barely had time to celebrate the landmark approval of its pancreatic cancer pill before Wall Street demanded to know what's next.Late last month, regulators approved daraxonrasib ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","LU1585245621.USD","LU0114720955.EUR","LU1868837300.USD","LU0456855351.SGD","BK4588","BK4585","BK4581","IE00BSNM7G36.USD","LU1868836757.USD","IE0002141913.USD","PTH","LU0432979614.USD","LU0868494617.USD","IHE","LU1868836591.USD","LU1983299246.USD","FTXH","LU0985481810.HKD","LU1032466523.USD","IE00BFXG1179.USD","LU2125154935.USD","IDNA","LU0882574055.USD","BK4559","LU0109394709.USD","LU1718418525.SGD","LU1236620834.HKD","IE0009355771.USD","LU0267386448.USD","BK4534","LU1093756168.USD","LU0237698245.USD","LU1670711040.USD","LU2360032135.SGD","LU1571399168.USD","LU1670710588.SGD","BBH","CANC","LU0096364046.USD","LU2133065610.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0306806265.USD","BMY","LU0321505439.SGD","IE0009354923.USD","LU0321505868.SGD","LU1236620750.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666107590","title":"AbbVie Declares Quarterly Cash Dividend of $1.73 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666107590","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666107590?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:18","pubTimestamp":1789064322,"startTime":"0","endTime":"0","summary":"AbbVie declares quarterly cash dividend of $1.73 a shareAbbVie declared a quarterly cash dividend of $1.73 per share.Dividend payable Nov. 16, 2026, to stockholders of record as of Oct. 15, 2026.Discl","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL5lD9cS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1923622614.USD","IXJ","LU0738911758.USD","LU1244550577.SGD","LU2237443622.USD","LU1023059063.AUD","FTXH","LU0211327993.USD","LU2133065610.SGD","TRUH","IE0002141913.USD","LU2129689431.USD","LU0234570918.USD","JDOC","LU2089283258.USD","IYH","XLV","FHLC","IE00BVYPNW00.USD","AGNG","GLAM","LU1839511570.USD","PPH","IE00B4R5TH58.HKD","LU1496350171.SGD","LU2089284900.SGD","PJP","LU0820561818.USD","LU1244550221.USD","LU0289739343.SGD","RXL","BK4588","LU0985320562.USD","LU0689472784.USD","LU0472753341.HKD","IE00BJT1NW94.SGD","LU1003077747.HKD","LU1093756325.SGD","LU2237443382.USD","LU2125909593.SGD","SG9999001440.SGD","LU2433249047.HKD","ABBV","LU0965509010.AUD","LU2129689514.USD","LU1037948897.HKD","VHT","MEDX","LU1430594728.SGD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590101","title":"Abbvie - Declares Qtrly Cash Dividend of $1.73 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666590101?lang=en_us&edition=fundamental","pubTime":"2026-09-11 02:18","pubTimestamp":1789064315,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nFWN4520NY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLAM","LU1496350171.SGD","LU0069063385.USD","BK4581","IYH","LU1236620834.HKD","LU0985320562.USD","SG9999015978.USD","LU1267930573.SGD","LU1093756325.SGD","LU2237443622.USD","LU2125909593.SGD","FTXH","LU2087621335.USD","LU0310800379.SGD","XLV","LU2468319806.SGD","IXJ","MEDX","PPH","VHT","JDOC","IE0002270589.USD","LU2112291526.USD","BK4588","FHLC","LU1057294990.SGD","LU0310799852.SGD","LU0511384066.AUD","LU1074936037.SGD","LU1162221912.USD","LU1496350502.SGD","TRUH","IE000BZT7R73.USD","BK4139","LU0868494708.USD","RXL","PJP","LU2237443465.HKD","LU0949170772.SGD","LU0320765646.SGD","AGNG","IE00BLSP4239.USD","LU1244550577.SGD","LU1732799900.SGD","LU1983299246.USD","IE000WAW04H5.SGD","ABBV","BK4550","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597348","title":"BMY Targets Pediatric MS Edge With New Ozanimod Study Against Fingolimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597348","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666597348?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:31","pubTimestamp":1789057896,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb is running a late stage study that pi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bmy-targets-pediatric-ms-edge-with-new-ozanimod-study-against-fingolimod?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bmy-targets-pediatric-ms-edge-with-new-ozanimod-study-against-fingolimod?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","BK4581","LU0237698245.USD","LU0432979614.USD","LU1571399168.USD","LU0096364046.USD","LU1430594728.SGD","LU1868836591.USD","LU1868837300.USD","LU0306807586.USD","IHE","LU0306806265.USD","LU0321505439.SGD","LU0321505868.SGD","LU0882574055.USD","LU2125154935.USD","LU1670711123.USD","LU1236620750.USD","IE00BJJMRZ35.SGD","LU1074936037.SGD","BMY","BK4585","LU1989771016.USD","BK4532","LU2133065610.SGD","BK4534","LU1032466523.USD","IE0002141913.USD","LU0225771236.USD","LU1236620834.HKD","IE00B2B36J28.USD","LU0456855351.SGD","LU1718418525.SGD","IE00BFXG1179.USD","LU1093756325.SGD","IE0009355771.USD","LU2125154778.USD","LU2360032135.SGD","IE00BSNM7G36.USD","LU1868837136.USD","LU1670710661.SGD","LU0114720955.EUR","LU1868836914.USD","LU2596442595.SGD","LU1670711040.USD","LU2242646821.SGD","BK4588","FTXH","BK4559","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597351","title":"Bristol-Myers Squibb’s Long-Term Psoriasis Study Brings Fresh Data for BMY Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597351","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666597351?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:30","pubTimestamp":1789057847,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb Co. (BMY) has completed a long-term P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibbs-long-term-psoriasis-study-brings-fresh-data-for-bmy-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibbs-long-term-psoriasis-study-brings-fresh-data-for-bmy-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","LU0432979614.USD","BK4007","LU0096364046.USD","LU2242652126.USD","LU1868837300.USD","LU1868836757.USD","LU0321505439.SGD","IHE","LU0306806265.USD","LU0321505868.SGD","LU0882574055.USD","LU1670711123.USD","LU1236620750.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU0985481810.HKD","LU1074936037.SGD","BMY","BK4585","LU1670710588.SGD","BK4532","BK4534","LU1032466523.USD","IE0002141913.USD","LU0225771236.USD","LU1236620834.HKD","ISBC","LU0868494617.USD","IE00B2B36J28.USD","LU1718418525.SGD","IE00BFXG1179.USD","IE0009355771.USD","LU2125154778.USD","LU2360032135.SGD","IE00BSNM7G36.USD","LU1291159041.SGD","LU1670710661.SGD","LU1323610961.USD","LU0114720955.EUR","LU1868836914.USD","LU2596442595.SGD","LU1670711040.USD","LU2242646821.SGD","LU1868837136.USD","LU1261432733.SGD","FTXH","BK4559","LU1585245621.USD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666597343","title":"Bladder Cancer Trial Completion Puts Opdivo in Focus for BMY and Ono Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666597343","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666597343?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:30","pubTimestamp":1789057826,"startTime":"0","endTime":"0","summary":"ONO Pharmaceutical Co ($OPHLF), Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Bristol-Myers Squibb and O...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bladder-cancer-trial-completion-puts-opdivo-in-focus-for-bmy-and-ono-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bladder-cancer-trial-completion-puts-opdivo-in-focus-for-bmy-and-ono-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505439.SGD","LU0456855351.SGD","LU2133065610.SGD","IE00BSNM7G36.USD","LU1670710588.SGD","LU0096364046.USD","LU1236620750.USD","LU0225771236.USD","LU1670710661.SGD","IE00BFXG1179.USD","IE0009355771.USD","BK4588","LU0061475181.USD","LU0267386448.USD","LU0868494617.USD","LU1093756325.SGD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU1430594728.SGD","LU1291159041.SGD","LU0306807586.USD","BK4559","BK4581","BK4007","LU1868837136.USD","LU1236620834.HKD","LU2360032135.SGD","BMY","IHE","LU1323610961.USD","LU0114720955.EUR","LU0321505868.SGD","LU2242652126.USD","ISBC","LU2242646821.SGD","LU1670711123.USD","LU1074936037.SGD","LU1585245621.USD","LU1093756168.USD","LU1571399168.USD","BK4585","FTXH","IE00BJJMRZ35.SGD","LU1868836914.USD","IE00BJT1NW94.SGD","LU0985481810.HKD","LU0882574055.USD","LU1868836591.USD","LU0225284248.USD","LU1868836757.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666973105","title":"AbbVie’s Eye Implant Study Delivers Fresh Real‑World Clarity for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666973105","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666973105?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:30","pubTimestamp":1789057812,"startTime":"0","endTime":"0","summary":"Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie is reporting new data from an observational eye study in adults with dia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abbvies-eye-implant-study-delivers-fresh-realworld-clarity-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abbvies-eye-implant-study-delivers-fresh-realworld-clarity-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU0726765562.USD","ABBV","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0820561818.USD","LU0256863902.USD","LU0211328371.USD","FHLC","LU0868494617.USD","LU2089284900.SGD","LU0417517546.SGD","AGNG","IE00B2B36J28.USD","TRUH","IYH","IXJ","VHT","LU0256863811.USD","LU0057025933.USD","LU1244550221.USD","XLV","LU1496350171.SGD","MEDX","LU0320765646.SGD","PJP","LU1839511570.USD","LU0738911758.USD","LU2433249047.HKD","GLAM","IE0002141913.USD","LU1061106388.HKD","LU0234570918.USD","IE00BBT3K403.USD","LU1003077747.HKD","IE00BDGV0183.EUR","IE000F7OJYX1.SGD","IE00B4R5TH58.HKD","ISBC","FTXH","LU2468319806.SGD","LU1074936037.SGD","LU0795875169.SGD","LU0203345920.USD","LU1585245621.USD","LU2237443895.HKD","RXL","PPH","LU2347655156.SGD","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666466592","title":"Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2666466592","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666466592?lang=en_us&edition=fundamental","pubTime":"2026-09-11 00:08","pubTimestamp":1789056517,"startTime":"0","endTime":"0","summary":"Cytokinetics (CYTK) likely has the upper hand in its patent dispute with Bristol-Myers Squibb (BMY) related to a patent for methods of treatment with cardiac myosin inhibitors, or CMIs, RBC Capital Ma","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0114720955.EUR","LU0267386448.USD","BK4559","LU0225771236.USD","LU0225284248.USD","BK4534","LU1868836757.USD","LU0306807586.USD","LU1868836914.USD","BK4139","BMY","LU0321505439.SGD","BK4532","LU0061475181.USD","BK4505","LU1868836591.USD","LU1989771016.USD","LU1718418525.SGD","LU0237698245.USD","IE00BJJMRZ35.SGD","LU1032466523.USD","LU2133065610.SGD","LU1236620750.USD","LU1323610961.USD","IHE","LU1430594728.SGD","IE00BJT1NW94.SGD","LU0456855351.SGD","LU1670710588.SGD","LU1868837136.USD","LU1093756325.SGD","BK4007","LU2242652126.USD","IE00BSNM7G36.USD","LU2596442595.SGD","FTXH","LU0321505868.SGD","LU0306806265.USD","IE00B2B36J28.USD","LU0432979614.USD","LU1093756168.USD","LU0985481810.HKD","LU1291159041.SGD","LU1670711123.USD","LU2125154935.USD","LU2360032135.SGD","CYTK","IE0002141913.USD","IE0009355771.USD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659414","title":"Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659414","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659414?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:04","pubTimestamp":1789052640,"startTime":"0","endTime":"0","summary":"Wachtell dealmaker jumps to Linklaters to bolster US buildoutSept 10 (Reuters)-Law firm Linklaters said on Thursday that it has hired longtime partner Mark Gordon from Wachtell, Lipton, Rosen & Katz, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL6N4520WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089283258.USD","LU2750360997.AUD","GDOC","LU0077335932.USD","RXL","LU1814569148.SGD","LU1355424745.HKD","LU0072461881.USD","TRUH","IE00B4R5TH58.HKD","IE00BLSP4452.SGD","IE00BDGV0183.EUR","LU1829250122.USD","FHLC","XLV","LU1084165304.USD","JDOC","IHE","LU2430703095.HKD","LU0211326839.USD","LU0960981461.USD","LU2112291526.USD","VHT","LU1323610961.USD","LU0496365809.HKD","LU0689472784.USD","FTXH","MEDX","LU0949170426.SGD","LU1880407215.USD","JHX","LU2089284900.SGD","IYH","LU0466842654.USD","AZN.UK","LU0053666078.USD","IE00B3PB1722.GBP","IE000SO60NU8.SGD","LU2293690082.USD","03165","LU0708994859.HKD","BMED","LU0210536198.USD","PJP","IXJ","LU1291159041.SGD","LU1989771016.USD","JNJ","LU0972486137.USD","IE00BVYPNW00.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591236","title":"Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591236","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666591236?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:31","pubTimestamp":1789050684,"startTime":"0","endTime":"0","summary":"Johnson & Johnson announces R$ 0.3 per unit dividend for 3Q 2026Johnson & Johnson declared a dividend of R$ 0.3 per unit for the third quarter of 2026.Last day to trade with dividend rights is Aug. 24","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8Bmdh0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2602419157.SGD","IE0002141913.USD","IE00BVYPNW00.USD","LU2471134952.CNY","LU0053666078.USD","IE00B1BXHZ80.USD","LU2750360641.GBP","LU1280957306.USD","IHE","LU2750360997.AUD","LU1506573853.SGD","LU0640476718.USD","RXL","IXJ","IE000SO60NU8.SGD","IYH","LU0345769631.USD","LU1244550494.USD","VHT","BMED","MEDX","LU2133065610.SGD","LU2430703251.USD","IE00BFXG1179.USD","LU2471134879.HKD","FTXH","IE00B3T34201.USD","LU0426417589.USD","LU0795875086.SGD","TRUH","JNJ","LU0320765646.SGD","PJP","LU1066051225.USD","LU0289739699.SGD","SG9999001440.SGD","IE000M9KFDE8.USD","JDOC","IE00BVYPNV92.GBP","LU0345769128.USD","LU2023250330.USD","BK4007","GDOC","IE00B19Z3B42.SGD","XLV","LU0683600562.USD","LU1267930813.SGD","FHLC","LU1057294990.SGD","LU1074936037.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666859902","title":"Bristol-Myers Squibb is Maintained at Hold by HSBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2666859902","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666859902?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:08","pubTimestamp":1789049280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMY/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0267386448.USD","LU0225771236.USD","HSBH","LU1670710661.SGD","LU2236285917.USD","LU0225284248.USD","BK4207","LU0306807586.USD","BMY","LU0496365809.HKD","LU1571399168.USD","LU1883839398.USD","BK4532","BK4521","LU0061475181.USD","LU1868836591.USD","LU1989771016.USD","LU1585245621.USD","LU0976567544.SGD","HSBC","LU1718418525.SGD","IE00BFXG1179.USD","LU0237698245.USD","LU1032466523.USD","LU2133065610.SGD","LU1323610961.USD","IHE","LU1670710588.SGD","LU1868837136.USD","LU1093756325.SGD","BK4007","LU0882574055.USD","BK4585","IE00BFTCPJ56.SGD","FTXH","LU0321505868.SGD","LU0306806265.USD","LU1291159041.SGD","LU2125154935.USD","LU1093756168.USD","LU0985481810.HKD","LU1670711123.USD","LU2360032135.SGD","BK4581","LU0456855351.SGD","IE0002141913.USD","LU1983299246.USD","IE0009355771.USD","LU1074936037.SGD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666066599","title":"Eli Lilly is Maintained at Reduce by HSBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2666066599","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666066599?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:06","pubTimestamp":1789049160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LLY/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU1720051017.SGD","JDOC","SG9999001176.SGD","LU2237443465.HKD","LU0471298777.SGD","PJP","SG9999017495.SGD","LU0943347566.SGD","SG9999014898.SGD","LU0158827781.USD","IE00BKDWB100.SGD","LU2491049909.HKD","LU1868837300.USD","IE00B7KXQ091.USD","IE00BJLML261.HKD","LU2750360641.GBP","FHLC","LU2271345857.HKD","LLII","LU1814569148.SGD","LU2089284900.SGD","LU0672654240.SGD","RXL","LU0316494557.USD","IE00BFSS8Q28.SGD","LU0061475181.USD","HRTS","IE00B4JS1V06.HKD","IE00B4R5TH58.HKD","MHIP","SGXZ81514606.USD","SG9999015978.USD","LU2237443549.SGD","GB00BDT5M118.USD","LU2168563687.JPY","LU0096364046.USD","LU2211815571.USD","IE00B1BXHZ80.USD","LU0320765992.SGD","LU2087625088.SGD","TRUH","LU0106261372.USD","LU1035775433.USD","LU1868836757.USD","LU1979441026.SGD","SG9999001176.USD","LU0114720955.EUR","LU1983299246.USD","LU1061106388.HKD","LU2108987350.USD","IE0005OL40V9.USD","LU0225283273.USD","MEDI","LU2552382132.HKD","IE00BK4W5M84.HKD","TMED","LU0198837287.USD","LU1868836914.USD","LU2237443622.USD","SG9999015945.SGD","SG9999018865.SGD","LU2237443382.USD","LU1712237335.SGD","LU1551013425.SGD","LU0823434583.USD","LU0122379950.USD","LU2213496289.HKD","BK4599","LU2462591350.SGD","LU0203201768.USD","IE00BK4W5L77.USD","SGXZ57979304.SGD","LU2361045086.USD","LU1064131342.USD","LU0471298694.HKD","LU2168564495.EUR","LU2023250330.USD","LU1917777945.USD","CANC","SG9999015952.SGD","LU0787776722.HKD","SG9999014914.USD","LU1629891620.HKD","LU1868836591.USD","IE00BJT1NW94.SGD","IE0004445015.USD","LU1145028129.USD","LU0823416689.USD","LU2417539215.USD","LU1280957306.USD","LU2324357040.USD","LU0158827948.USD","LU0345770993.USD","IE00B775H168.HKD","LU2602419157.SGD","LU0174119429.USD","LU0238689110.USD","FTXH","LU1267930730.SGD","LU2089283258.USD","LU2237438978.USD","LU2168564065.EUR","IE00BN29S564.USD","LU2471134952.CNY","LU2552382058.USD","LU0385154629.USD","LU2746668974.SGD","LU0689472784.USD","LU2491050154.USD","SGXZ99366536.SGD","XLV","LU1623119135.USD","LU0354030438.USD","IE00BJJMRY28.SGD","LU2361044865.SGD","LU2106854487.HKD","LU0079474960.USD","THNR","BK4007","LU0345770308.USD","LU0256863811.USD","LU0683600562.USD","LU0109394709.USD","LU0353189763.USD","LU1093756168.USD","LU1366192091.USD","IE00BFSS7M15.SGD","LU0203202063.USD","SG9999013999.USD","IE00B2B36J28.USD","LU1023059063.AUD","ELIS","LU2552382215.SGD","IE00B1XK9C88.USD","LU2756315664.SGD","LU0882574055.USD","LU1291159041.SGD","LU2468319806.SGD","LU0097036916.USD","LU0964807845.USD","LU0820561909.HKD","SGXZ31699556.SGD","IHE","BK4533","LU2756315318.SGD","LU2471134879.HKD","LU1868837136.USD","LU1804176565.USD","LU0786609619.USD","WDNA","LU2491050071.SGD","CURE","LU2360106947.USD","LU0058720904.USD","LU2063271972.USD","LU2089984988.USD","IXJ","BK4534","LU0289739699.SGD","LU1057294990.SGD","LU0006306889.USD","IE0004445239.USD","LU1548497426.USD","LU2111349929.HKD","PPH","LLYX","LU0353189680.USD","LU0323591593.USD","LU0640476718.USD","OZEM","SG9999014906.USD","IE00BJJMRX11.SGD","LU0708995401.HKD","LU0210536198.USD","LU0256863902.USD","LU1691799644.USD","LU1093756325.SGD","LU1127390331.HKD","LU0234572021.USD","SG9999014880.SGD","LU2456880835.USD","IE00BWXC8680.SGD","LU2462157665.USD","LU1551013342.USD","IE00BJJMRZ35.SGD","LU2168564222.USD","LU1069344957.HKD","LU1974910355.USD","LU2237443978.SGD","SG9999018857.SGD","IYH","LU2471134796.USD","LU0417517546.SGD","LU2357305700.SGD","LU2361044949.HKD","LU2237443895.HKD","LU2750360997.AUD","AGNG","BK4516","LU2746668461.USD","LU2028103732.USD","LU0466842654.USD","ILDR","LU0432979614.USD","LU2264538146.SGD","LU2265009873.SGD","SGXZ51526630.SGD","ELIL","LU2023251221.USD","LU1989771016.USD","VHT","IE00BKPKM429.USD","IE0009355771.USD","LU0320765059.SGD","LU0889565916.HKD","LU0456855351.SGD","BK4588","LU1988902786.USD","LU0109391861.USD","LU0820561818.USD","LU1720051108.HKD","LU2896262040.SGD","LU2471134523.USD","LU2236285917.USD","LU1323610961.USD","SG9999015986.USD","LU0094547139.USD","LU0823434740.USD","GDOC","LU1232071149.USD","LU2023250504.SGD","LU0133085943.USD","LU2461242641.AUD","MEDX","IE00BFTCPJ56.SGD","LU0354030511.USD","LU0882574139.USD","BK4585","LU0820562030.AUD","IE0002141913.USD","LLY","IE0001KFT4U8.USD","LLYZ","LU2168564149.EUR","LU0266013472.USD","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666599172","title":"Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2666599172","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666599172?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:54","pubTimestamp":1789048478,"startTime":"0","endTime":"0","summary":"MEDIA-Eli Lilly’s GLP-1 windfall to fund push into women’s health - Bloomberg News-- Source link: https://tinyurl.com/327fb793-- Note: Reuters has not verified this story and does not vouch for its accuracy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL6N4520XF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFSS7M15.SGD","LU1548497426.USD","BK4581","LU2456880835.USD","LU1291159041.SGD","GDOC","LU2106854487.HKD","SG9999013999.USD","THNR","LU2168564222.USD","LU0820562030.AUD","PJP","SGXZ57979304.SGD","BK4599","LU2237443382.USD","BK4516","LU2417539215.USD","LU2361045086.USD","ELIS","LU2756315664.SGD","SGXZ99366536.SGD","LU2089284900.SGD","LU0640476718.USD","LLYZ","LU2461242641.AUD","LU0096364046.USD","LU1629891620.HKD","SGXZ81514606.USD","SG9999014880.SGD","LU0320765059.SGD","LU2108987350.USD","LU0133085943.USD","LU0323591593.USD","TRUH","LU2237443622.USD","LU2265009873.SGD","LU1868837136.USD","LU0683600562.USD","LU1868837300.USD","LU2471134796.USD","LU2112291526.USD","SG9999018865.SGD","LU0174119429.USD","LU1061106388.HKD","LU0943347566.SGD","IHE","LLYX","LU2324357040.USD","LU2471134879.HKD","PPH","LU0964807845.USD","BK4585","LU0097036916.USD","LU1551013342.USD","LU2237438978.USD","LU0787776722.HKD","IE00BJJMRY28.SGD","LU1868836757.USD","LU1804176565.USD","LU1093756168.USD","LU2746668461.USD","LU0094547139.USD","LU0210536198.USD","BK4533","LU0345770308.USD","LU2063271972.USD","LU2089984988.USD","SG9999014898.SGD","BK4007","LU0385154629.USD","IE00BK4W5L77.USD","LU1551013425.SGD","LU1366192091.USD","SG9999018857.SGD","ILDR","LU0079474960.USD","LU2360106947.USD","LU1974910355.USD","LU2237443895.HKD","SG9999015986.USD","HRTS","OZEM","GB00BDT5M118.USD","IE0009355771.USD","LU0061475181.USD","SGXZ51526630.SGD","LU0122379950.USD","LU2491050154.USD","LU1127390331.HKD","IE00B4JS1V06.HKD","LU1720051108.HKD","LU0353189680.USD","SG9999017495.SGD","FTXH","IE00BFTCPJ56.SGD","LU0106261372.USD","LU1093756325.SGD","VHT","LU0234572021.USD","LU0820561818.USD","IE00BJLML261.HKD","LU2028103732.USD","IE0004445239.USD","LU0354030438.USD","LU2211815571.USD","LU1069344957.HKD","LU1232071149.USD","LU0456855351.SGD","LU2023250504.SGD","LU2089283258.USD","LU2168564149.EUR","CANC","RXL","AGNG","WDNA","LU0471298694.HKD","IE00B7KXQ091.USD","JDOC","LU0471298777.SGD","LU1868836914.USD","LU2264538146.SGD","XLV","IE0002141913.USD","LU2361044865.SGD","LU0198837287.USD","LU1917777945.USD","LU1623119135.USD","LU0823434740.USD","IE00BWXC8680.SGD","LU1280957306.USD","LU2552382058.USD","SG9999015978.USD","IE00BN29S564.USD","LU1035775433.USD","LU0238689110.USD","SG9999014914.USD","LU0889565916.HKD","IE00BFSS8Q28.SGD","LU2111349929.HKD","IE00B2B36J28.USD","IE0005OL40V9.USD","LU1057294990.SGD","IE00BKDWB100.SGD","LU0345770993.USD","LU2236285917.USD","MEDI","LU0316494557.USD","LU0672654240.SGD","IE00B1XK9C88.USD","LU2168563687.JPY","LU2357305700.SGD","IE00BJJMRX11.SGD","LU1691799644.USD","LU1983299246.USD","LU2237443465.HKD","ELIL","LU0109391861.USD","LU2491050071.SGD","LU2023250330.USD","LU1868836591.USD","LU1064131342.USD","LU1023059063.AUD","LU0708995401.HKD","LLII","LU2237443549.SGD","IE0004445015.USD","LU0417517546.SGD","IYH","IE00B4R5TH58.HKD","LU0203202063.USD","BK4534","LU0058720904.USD","LU0256863902.USD","LU1145028129.USD","LU1267930730.SGD","LU0882574055.USD","LU2213496289.HKD","LU2552382132.HKD","LU0225283273.USD","MEDX","IE0001KFT4U8.USD","LU1979441026.SGD","LU0256863811.USD","LU0266013472.USD","IE00BK4W5M84.HKD","IE00BKPKM429.USD","LU0786609619.USD","LU0823434583.USD","LU0320765992.SGD","LU2087625088.SGD","LU0006306889.USD","LU2271345857.HKD","LU2468319806.SGD","SG9999001176.USD","LU2746668974.SGD","LU2462157665.USD","CURE","LU0820561909.HKD","LU2023251221.USD","LU2471134523.USD","LU2491049909.HKD","SGXZ31699556.SGD","LU1323610961.USD","IE00B775H168.HKD","LU0203201768.USD","LU0353189763.USD","LU1814569148.SGD","LU0109394709.USD","LU0466842654.USD","LU2471134952.CNY","LU2602419157.SGD","LU0823416689.USD","LU2361044949.HKD","SG9999001176.SGD","TMED","LU2756315318.SGD","LU2237443978.SGD","LU2168564065.EUR","FHLC","LU0289739699.SGD","SG9999015945.SGD","LU1712237335.SGD","LU1988902786.USD","LU0689472784.USD","LU0882574139.USD","LU1720051017.SGD","IE00B1BXHZ80.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU2750360641.GBP","LU2896262040.SGD","MHIP","LU2168564495.EUR","LU0158827948.USD","LU0158827781.USD","LU2750360997.AUD","LU0114720955.EUR","SG9999015952.SGD","IE00BJT1NW94.SGD","LU1989771016.USD","LLY","LU2462591350.SGD","SG9999014906.USD","IXJ","BK4588","LU2552382215.SGD","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596073","title":"AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596073","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596073?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:30","pubTimestamp":1789047005,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) said Thursday that atogepant for the preventive treatment of menstrual migraine in adults met its primary and all eight ranked secondary endpoints in the Phase 3 LUNA study.Atogepant dem","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0211328371.USD","LU0708994859.HKD","FHLC","LU2237443622.USD","PJP","LU0820561909.HKD","LU2125909247.SGD","XLV","LU1061106388.HKD","IE00BVYPNV92.GBP","LU1934455863.HKD","LU0511384066.AUD","GLAM","IE00BJT1NW94.SGD","BK4139","LU0985320562.USD","ABBV","FTXH","SG9999003800.SGD","LU0029864427.USD","SG9999015986.USD","IE00B19Z3B42.SGD","LU1037948897.HKD","LU0965509101.SGD","LU0820561818.USD","LU0882574055.USD","LU1236620834.HKD","LU2129689514.USD","LU0456855351.SGD","RXL","IE00BLSP4452.SGD","PPH","IYH","SG9999001440.SGD","IE0004445239.USD","LU1244550577.SGD","TRUH","JDOC","BK4534","LU2347655156.SGD","LU1244550221.USD","MEDX","IE00BLSP4239.USD","AGNG","IXJ","LU0912757837.SGD","IE00BSNM7G36.USD","LU0395794307.EUR","VHT","LU1496350171.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596813","title":"AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596813","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596813?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:00","pubTimestamp":1789045214,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced positive topline results from the Phase 3 LUNA study, which evaluated atogepant, a calcitonin gene-related peptide, or CGRP...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvies-atogepant-shows-positive-phase-3-results-in-menstrual-migraine-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvies-atogepant-shows-positive-phase-3-results-in-menstrual-migraine-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU2237443382.USD","JDOC","IYH","LU0553294199.USD","LU2237443465.HKD","PJP","BK4550","AGNG","LU0795875086.SGD","IE00B2B36J28.USD","FHLC","RXL","VHT","LU0726765562.USD","LU0965508806.USD","LU1670628061.USD","LU1236620834.HKD","LU1989772923.USD","LU0823416689.USD","BK4588","LU0661504455.SGD","IE0000B7K699.USD","LU0203345920.USD","LU0128525929.USD","LU2089984988.USD","IXJ","TRUH","BK4534","FTXH","LU0289739699.SGD","LU1057294990.SGD","LU0859254822.USD","PPH","MEDX","IE000MB6IJN5.SGD","LU0949170772.SGD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0170899867.USD","LU1934455863.HKD","LU2357627491.SGD","XLV","IE00BN8TJ469.HKD","ABBV","BK4139","IE00BBT3K403.USD","GLAM","LU0256863811.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666954045","title":"Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals","url":"https://stock-news.laohu8.com/highlight/detail?id=2666954045","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666954045?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739343.SGD","IE00BN8TJ469.HKD","BK4581","GLAM","LU2125909247.SGD","JDOC","RXL","LU1929549753.HKD","LU2125909593.SGD","IE000BZT7R73.USD","XLV","LU0456855351.SGD","LU0417517546.SGD","IE00BGHQF631.EUR","BK4559","FTXH","AGNG","LU1267930573.SGD","IE00BDGV0183.EUR","SG9999001440.SGD","LU0689626769.HKD","LU1291159041.SGD","LU1496350171.SGD","LU0820561909.HKD","LU2433249047.HKD","LU0158827948.USD","LU0124676726.USD","VHT","LU0289961442.SGD","ABBV","SG9999015978.USD","LU0949170772.SGD","LU0726765562.USD","MEDX","LU0545039389.USD","FHLC","LU2133065610.SGD","SG9999015986.USD","LU0170899867.USD","LU1732800096.USD","LU1989772923.USD","TRUH","IXJ","IE00BLSP4239.USD","LU1934455194.USD","IYH","PPH","LU0965508806.USD","LU1244550494.USD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666595402","title":"Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666595402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666595402?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:55","pubTimestamp":1789044900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RPXBH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FHLC","LU1983299246.USD","LU2237443549.SGD","LU1670628061.USD","RXL","LU2347655156.SGD","LU0965509010.AUD","LU0472753341.HKD","LU1244550221.USD","LU0432979614.USD","LU0203347892.USD","IE00B3PB1722.GBP","LU1934455194.USD","LU2089984988.USD","IE0004445239.USD","AGNG","LU1037948897.HKD","LU1093756168.USD","LU1551013425.SGD","PJP","TRUH","IE00BFTCPJ56.SGD","IXJ","LU1496350502.SGD","FTXH","MEDX","IE000BZT7R73.USD","LU0158827948.USD","XLV","IE0002141913.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU2089283258.USD","PPH","LU0553294199.USD","LU1934455863.HKD","ABBV","JDOC","IE00B42XCP33.USD","LU0795875169.SGD","BK4559","LU1718418525.SGD","VHT","GLAM","LU0820561909.HKD","LU0395794307.EUR","LU1244550577.SGD","IYH","LU0122379950.USD","LU1732800096.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}